Collecting Duct Carcinoma Survival Rate

Symptoms may include flank pain unexplained weight loss or blood in the urine.

Collecting duct carcinoma survival rate.

Histochemical and immunohistochemical studies are often necessary for the diagnosis of collecting duct carcinoma. Collecting duct carcinoma cdc is a rare aggressive form of renal carcinoma that presents at an advanced stage and has a poor prognosis. Collecting duct carcinoma and renal medullary carcinoma are aggressive types of kidney cancer which doctors find challenging to treat. Little is known concerning the optimal management of cdc.

We present the results of a systematic review addressing the management of cdc and the mcmaster university cdc series. Many people with cdc have no signs or symptoms until the cancer is at an advanced stage. 1 these tumours are found to be locally advanced and with distant metastasis at presentation with 1 to 3 years disease specific survival. The prognosis is poor and most patients develop metastases or die 120 121 136 137 within 2 years of presentation.

Collecting duct carcinomas are rare aggressive malignancies with poor prognosis arising from collecting duct epithelium of the kidney accounting for about 1 3 of all renal cell carcinoma rcc.